Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology

SA Kozek-Langenecker, A Afshari… - European Journal of …, 2013 - journals.lww.com
The aims of severe perioperative bleeding management are three-fold. First, preoperative
identification by anamesis and laboratory testing of those patients for whom the …

Effect of study setting on anticoagulation control: a systematic review and metaregression

C van Walraven, A Jennings, N Oake, D Fergusson… - Chest, 2006 - Elsevier
Background For patients receiving therapy with oral anticoagulants (OACs), the proportion of
time spent in the therapeutic range (ie, anticoagulation control) is strongly associated with …

Cardiovascular, bleeding, and mortality risks in elderly Medicare patients treated with dabigatran or warfarin for nonvalvular atrial fibrillation

DJ Graham, ME Reichman, M Wernecke, R Zhang… - Circulation, 2015 - Am Heart Assoc
Background—The comparative safety of dabigatran versus warfarin for treatment of
nonvalvular atrial fibrillation in general practice settings has not been established. Methods …

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis …

L Wallentin, S Yusuf, MD Ezekowitz, M Alings… - The Lancet, 2010 - thelancet.com
Background Effectiveness and safety of warfarin is associated with the time in therapeutic
range (TTR) with an international normalised ratio (INR) of 2· 0–3· 0. In the Randomised …

Early hypo-attenuated leaflet thickening in balloon-expandable transcatheter aortic heart valves

G Pache, S Schoechlin, P Blanke, S Dorfs… - European heart …, 2016 - academic.oup.com
Aims We sought to evaluate the frequency of early hypo-attenuated leaflet thickening (HALT)
of the SAPIEN 3 transcatheter aortic valve (S3). Methods and results Of 249 patients who …

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and …

SJ Connolly, J Pogue, J Eikelboom, G Flaker… - Circulation, 2008 - Am Heart Assoc
Background—Oral anticoagulation (OAC) therapy is effective in atrial fibrillation but requires
vigilance to maintain the international normalized ratio in the therapeutic range. This report …

Stroke, bleeding, and mortality risks in elderly medicare beneficiaries treated with dabigatran or rivaroxaban for nonvalvular atrial fibrillation

DJ Graham, ME Reichman, M Wernecke… - JAMA internal …, 2016 - jamanetwork.com
Importance Dabigatran and rivaroxaban are non–vitamin K oral anticoagulants approved for
stroke prevention in patients with nonvalvular atrial fibrillation (AF). There are no …

Assessment of laboratory assays to measure rivaroxaban–an oral, direct factor Xa inhibitor

MM Samama, JL Martinoli, L LeFlem… - Thrombosis and …, 2010 - thieme-connect.com
Although there is no need for routine coagulation monitoring with rivaroxaban–an oral, direct
factor Xa inhibitor–a haemostasis assay might be valuable to measure its pharmacodynamic …

Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States

WL Baker, DA Cios, SD Sander, CI Coleman - Journal of Managed Care …, 2009 - jmcp.org
BACKGROUND: Atrial fibrillation (AF) affects a significant proportion of the American
population and increases ischemic stroke risk by 4-to 5-fold. Oral vitamin K antagonists …

Atrial fibrillation: current knowledge and future directions in epidemiology and genomics

JW Magnani, M Rienstra, H Lin, MF Sinner, SA Lubitz… - Circulation, 2011 - Am Heart Assoc
Atrial fibrillation (AF) is of public health importance and profoundly increases morbidity,
mortality, and healthrelated expenditures. Morbidities include the increased risks of …